We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M Turnover 90.24%
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$403M
AUM Growth
+$250M
Cap. Flow
+$235M
Cap. Flow %
58.3%
Top 10 Hldgs %
6.29%
Holding
793
New
457
Increased
87
Reduced
29
Closed
219
Avg Time Held
0.1 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.8M
2
TGT icon
Target
TGT
+$2.73M
3
LMT icon
Lockheed Martin
LMT
+$2.7M
4
DLTR icon
Dollar Tree
DLTR
+$2.53M
5
NOC icon
Northrop Grumman
NOC
+$2.29M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$2.59M
2
AAPL icon
Apple
AAPL
+$2.41M
3
CAG icon
Conagra Brands
CAG
+$1.87M
4
RHT
Red Hat Inc
RHT
+$1.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 21.61%
2 Consumer Discretionary 19.21%
3 Industrials 13.4%
4 Healthcare 12.85%
5 Financials 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RTX icon
476
RTX Corp
RTX
$261B
$243K 0.06%
3,521
-5,724
-62% -$379K
2016 Q3
1 quarter
ZBRA icon
477
Zebra Technologies
ZBRA
$17.5B
$243K 0.06%
2,832
-5,654
-67% -$419K
2016 Q3
1 quarter
Z icon
478
Zillow
Z
$6.93B
$237K 0.06%
+6,500
New +$229K
2016 Q4
0 quarters
VSA icon
479
VisionSys AI
VSA
$5.36M
$235K 0.06%
+6
New +$231K
2016 Q4
0 quarters
ENTA icon
480
Enanta Pharmaceuticals
ENTA
$323M
$234K 0.06%
+6,989
New +$200K
2016 Q4
0 quarters
EVH icon
481
Evolent Health
EVH
$517M
$234K 0.06%
+15,821
New +$312K
2016 Q4
0 quarters
OSG icon
482
Octave Specialty Group
OSG
$210M
$231K 0.06%
+10,273
New +$224K
2016 Q4
0 quarters
SCMP
483
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$231K 0.06%
+17,059
New +$238K
2016 Q4
0 quarters
CCRN icon
484
DELISTED
Cross Country Healthcare
CCRN
$230K 0.06%
+14,748
New +$202K
2016 Q4
0 quarters
MGA icon
485
Magna International
MGA
$17.7B
$230K 0.06%
+5,300
New +$223K
2016 Q4
0 quarters
PCG icon
486
PG&E
PCG
$39.3B
$230K 0.06%
+3,792
New +$227K
2016 Q4
0 quarters
NKE icon
487
Nike
NKE
$55.1B
$229K 0.06%
+4,500
New +$231K
2016 Q4
0 quarters
TOL icon
488
Toll Brothers
TOL
$12.3B
$229K 0.06%
+7,400
New +$219K
2016 Q4
0 quarters
VCRA
489
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$228K 0.06%
+12,306
New +$220K
2016 Q4
0 quarters
WD icon
490
Walker & Dunlop
WD
$1.12B
$227K 0.06%
+7,261
New +$204K
2016 Q4
0 quarters
MSM icon
491
MSC Industrial Direct
MSM
$7.28B
$226K 0.06%
+2,449
New +$202K
2016 Q4
0 quarters
UAL icon
492
United Airlines
UAL
$31.2B
$226K 0.06%
+3,100
New +$198K
2016 Q4
0 quarters
VECO icon
493
Veeco
VECO
$2.61B
$224K 0.06%
7,700
-2,300
-23% -$57.5K
2016 Q3
1 quarter
LDL
494
DELISTED
Lydall, Inc.
LDL
$221K 0.05%
+3,581
New +$198K
2016 Q4
0 quarters
FBIN icon
495
Fortune Brands Innovations
FBIN
$4.78B
$219K 0.05%
+4,798
New +$226K
2016 Q4
0 quarters
AMSF icon
496
AMERISAFE
AMSF
$468M
$218K 0.05%
+3,500
New +$212K
2016 Q4
0 quarters
WCG
497
DELISTED
Wellcare Health Plans, Inc.
WCG
$217K 0.05%
1,580
-2,889
-65% -$368K
2016 Q2
2 quarters
TRU icon
498
TransUnion
TRU
$14.2B
$216K 0.05%
+6,979
New +$219K
2016 Q4
0 quarters
TPC icon
499
Tutor Perini Cor
TPC
$4.08B
$216K 0.05%
+7,710
New +$187K
2016 Q4
0 quarters
KNGT
500
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$215K 0.05%
+6,500
New +$215K
2016 Q4
0 quarters

Similar funds

Bayesian Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Bayesian Capital Management held 793 positions worth $403M, up 164% from $152M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Bayesian Capital Management deployed $235M of net new capital in Q4 2016, opening 457 new positions and adding to 87 existing holdings. Its largest new stake was Procter & Gamble: 32,800 shares worth $2.76M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Zebra Technologies, an estimated $419K trimmed.

  • Bayesian Capital Management's largest Q4 2016 buy was Procter & Gamble: 32,800 shares worth $2.76M.
  • Bayesian Capital Management added most to Ross Stores in Q4 2016, an estimated $1.85M increase.
  • Bayesian Capital Management's biggest Q4 2016 reduction was Zebra Technologies, cutting an estimated $419K.
  • Bayesian Capital Management fully exited Adobe in Q4 2016, selling an estimated $2.59M.
  • Bayesian Capital Management's ten largest holdings make up 6.3% of its $403M portfolio in Q4 2016.
  • Bayesian Capital Management opened 457 new positions and closed 219 in Q4 2016.
  • Bayesian Capital Management's portfolio value rose 164% quarter-over-quarter to $403M.

Based on Bayesian Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.